Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $6,075 | 11 | 49.1% |
| Food and Beverage | $3,920 | 186 | 31.7% |
| Travel and Lodging | $2,374 | 9 | 19.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $6,827 | 9 | $0 (2024) |
| Penumbra, Inc. | $2,508 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $901.81 | 83 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $417.49 | 33 | $0 (2020) |
| LivaNova USA, Inc. | $406.98 | 7 | $0 (2023) |
| Olympus America Inc. | $299.48 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $263.84 | 17 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $155.11 | 6 | $0 (2024) |
| Insmed, Inc. | $126.90 | 7 | $0 (2024) |
| Genentech USA, Inc. | $91.65 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,416 | 19 | INTUITIVE SURGICAL, INC. ($3,000) |
| 2023 | $6,812 | 31 | Intuitive Surgical, Inc. ($3,827) |
| 2022 | $447.26 | 13 | Penumbra, Inc. ($151.62) |
| 2021 | $99.92 | 7 | GlaxoSmithKline, LLC. ($32.44) |
| 2020 | $146.99 | 9 | Sunovion Pharmaceuticals Inc. ($55.10) |
| 2019 | $551.59 | 42 | Sunovion Pharmaceuticals Inc. ($271.62) |
| 2018 | $252.97 | 25 | GlaxoSmithKline, LLC. ($197.74) |
| 2017 | $642.62 | 60 | GlaxoSmithKline, LLC. ($377.15) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.78 | General |
| 10/16/2024 | Siemens Medical Solutions USA, Inc. | Cios Spin (Device) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: AT - Mobile interventional x-ray/angiography fluoroscopy | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.56 | General |
| 09/19/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | Olympus America Inc. | Spiration Valve System (Device) | Food and Beverage | In-kind items and services | $110.07 | General |
| Category: Endotherapy | ||||||
| 08/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.02 | General |
| 06/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.83 | General |
| 05/28/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: HFCWO | ||||||
| 05/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.03 | General |
| 04/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Respiratory | ||||||
| 04/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.03 | General |
| 02/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Respiratory | ||||||
| 02/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.59 | General |
| 02/01/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Education | In-kind items and services | $11.59 | General |
| Category: COVID-19 | ||||||
| 01/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 01/17/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 12/08/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: COVID-19 | ||||||
| 12/05/2023 | LivaNova USA, Inc. | LIFESPARC (Device) | Food and Beverage | In-kind items and services | $94.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $135.00 | General |
| Category: SURGERY | ||||||
| 11/19/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $75.00 | General |
| Category: SURGERY | ||||||
| 11/08/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 11/08/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: COVID-19 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,061 | 1,487 | $376,301 | $136,173 |
| 2022 | 18 | 1,390 | 1,919 | $425,638 | $156,527 |
| 2021 | 21 | 1,643 | 2,409 | $566,293 | $211,862 |
| 2020 | 24 | 1,754 | 2,574 | $616,743 | $224,478 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 128 | 314 | $167,048 | $51,689 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 276 | 431 | $88,355 | $36,814 | 41.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 142 | 205 | $40,590 | $18,678 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 98 | $13,622 | $5,486 | 40.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 49 | $12,887 | $4,836 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $12,324 | $4,560 | 37.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 65 | $8,905 | $3,966 | 44.5% |
| 32550 | Insertion of indwelling tube for drainage of lung fluid | Facility | 2023 | 16 | 18 | $11,898 | $2,755 | 23.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $2,178 | $2,070 | 95.0% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 15 | 18 | $6,179 | $1,466 | 23.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $960.00 | $915.20 | 95.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 11 | 11 | $4,785 | $886.85 | 18.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $2,328 | $768.00 | 33.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 51 | 51 | $1,224 | $469.20 | 38.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 60 | 60 | $2,100 | $464.92 | 22.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 51 | 51 | $918.00 | $348.33 | 37.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 114 | 303 | $161,196 | $51,939 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 287 | 476 | $97,580 | $42,106 | 43.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 161 | 233 | $46,134 | $18,379 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 142 | $19,738 | $8,483 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $19,276 | $7,012 | 36.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 81 | 124 | $16,988 | $6,878 | 40.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 56 | $14,728 | $5,917 | 40.2% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2022 | 27 | 35 | $11,857 | $2,826 | 23.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 43 | $2,838 | $2,783 | 98.1% |
About Dr. Thomas Waring, MD
Dr. Thomas Waring, MD is a Pulmonary Disease healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1588812564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Waring, MD has received a total of $12,369 in payments from pharmaceutical and medical device companies, with $3,416 received in 2024. These payments were reported across 206 transactions from 23 companies. The most common payment nature is "Education" ($6,075).
As a Medicare-enrolled provider, Waring has provided services to 5,848 Medicare beneficiaries, totaling 8,389 services with total Medicare billing of $729,039. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Owensboro, KY
- Active Since 09/03/2008
- Last Updated 10/20/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1588812564
Products in Payments
- Da Vinci Surgical System (Device) $6,827
- Indigo System (Device) $2,371
- ANORO (Drug) $461.53
- LIFESPARC (Device) $349.49
- LONHALA MAGNAIR (Drug) $308.15
- NUCALA (Biological) $141.59
- BREO (Drug) $140.67
- TRELEGY ELLIPTA (Drug) $134.63
- Arikayce (Drug) $126.90
- UPTRAVI (Drug) $119.28
- Spiration Valve System (Device) $110.07
- Veklury (Drug) $100.11
- Penumbra System (Device) $97.10
- Spin (Device) $85.13
- SPiN Thoracic Navigation System, 120V, 60Hz (Device) $69.49
- OFEV (Drug) $57.51
- LifeSPARC (Device) $57.49
- Esbriet (Biological) $56.85
- BROVANA (Drug) $50.23
- UTIBRON (Drug) $40.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Owensboro
Dr. Michael Muzoora, M.d, M.D
Pulmonary Disease — Payments: $19,126
Rejmon Dedaj, M.d, M.D
Pulmonary Disease — Payments: $16,219
Meliha Hrustanovic-Kadic, M.d, M.D
Pulmonary Disease — Payments: $872.62
William Obryan, Md, MD
Pulmonary Disease — Payments: $128.82